Asset Details
Do you wish to reserve the book?
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
Do you wish to request the book?
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
2020
Overview
In a large number of cancer types, treatment selection depends on the presence of specific tumor biomarkers. Due to the dynamic nature of cancer, very often these predictive biomarkers are not uniformly present in all cancer cells. Tumor heterogeneity represents indeed one of the main causes of therapeutic failure, and its decoding remains a major ongoing challenge in the field.
Liquid biopsy is the sampling and analysis of non-solid biological tissue often through rapid and non-invasive methods, which allows the assessment in real-time of the evolving landscape of cancer. Samples can be obtained from blood and most other bodily fluids. A blood-based liquid biopsy can capture circulating tumor cells and leukocytes, as well as circulating tumor-derived nucleic acids.
In this review, we discuss the current and possibly future applications of blood-based liquid biopsy in oncology, its advantages and its limitations in clinical practice. We specifically focused on its role as a tool to capture tumor heterogeneity in metastatic cancer patients.
Publisher
BioMed Central,BioMed Central Ltd,Springer Nature B.V,BMC
Subject
/ Animals
/ Biomarkers, Tumor - analysis
/ Biomarkers, Tumor - genetics
/ Biomedical and Life Sciences
/ Biopsy
/ Cancer
/ Circulating Tumor DNA - analysis
/ Circulating Tumor DNA - genetics
/ Cloning
/ Disease
/ Humans
/ Kinases
/ microRNA
/ Mutation
/ Neoplastic Cells, Circulating - metabolism
/ Neoplastic Cells, Circulating - pathology
/ Oncology
/ Peripheral blood mononuclear cells
/ Review
/ Tumors
